Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 10M - 10M
Notice Type:
Contract Notice
Published Date:
14 November 2023
Closing Date:
11 December 2023
Location(s):
FRL PROVENCE-ALPES-CÔTE D’AZUR (FR FRANCE)
Description:
Supply of injectable radiopharmaceuticals

the Framework Agreement will be implemented through the issuance of purchase orders. Each lot will be awarded separately. The services are regulated by unit prices. The estimated amounts are indicative and include all renewal periods

Molybdenum/Technetium Generator

Class 01 Radioactive products - Unit = generator with the activity best suited to the needs of the service - Maximum annual quantity: 104 units

fluoride-18 (18F-FDG)-labelled fluorodesoxyglucose in multi-dose vial

Class 01 Radioactive Products - Multi-allocation Lot (50/50) - Standard dose of 400mbq - Maximum annual quantity: 6000 doses

Bone vector

Class 02 Non-radioactive products - Unit = vial - Maximum annual quantity: 500 vials

pulmonary vector (perfusion)

Class 02 Non-radioactive products - Unit = vial - Maximum annual quantity: 200 vials

Biliary vector

Class 02 Non-radioactive products - Unit = vial - Maximum annual quantity: 30 vials

Download full details as .pdf
The Buyer:
ap-hm pour le compte du CHPA-CHIAP
CPV Code(s):
33600000 - Pharmaceutical products